COMPARISONS OF HOLISTIC PATIENT-REPORTED OUTCOMES BY BIOLOGIC DRUG CLASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REAL-WORLD STUDY IN IBD PARTNERS

被引：0
|
作者：
Long, Millie
Zhang, Xian
Chen, Wenli
Lissoos, Trevor
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P124
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] COMPARISONS OF HOLISTIC PATIENT-REPORTED OUTCOMES BY BIOLOGIC DRUG CLASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REAL-WORLD STUDY IN IBD PARTNERS
    Long, Millie
    Zhang, Xian
    Chen, Wenli
    Lissoos, Trevor
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S23 - S24
  • [2] The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
    Horrigan, Jamie M.
    Louis, Edouard
    Spinelli, Antonino
    Travis, Simon
    Moum, Bjorn
    Salwen-Deremer, Jessica
    Halfvarson, Jonas
    Panaccione, Remo
    Dubinsky, Marla C.
    Munkholm, Pia
    Siegel, Corey A.
    [J]. CROHNS & COLITIS 360, 2023, 5 (02)
  • [3] Use of Infliximab or Adalimumab in Biologic-Naive Patients With Inflammatory Bowel Disease: Study of Patient Reported Outcomes in IBD Partners
    Weaver, Kimberly
    Curtis, Jeffrey
    Beukelman, Tim
    Zhang, Xian
    Kappelman, Michael
    Long, Millie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S27 - S28
  • [4] EVOLUTION OF BIOLOGIC TREATMENT, SATISFACTION WITH CONTROL OF DISEASE, AND PATIENT-REPORTED OUTCOMES IN EUROPEAN PATIENTS WITH PSORIATIC ARTHRITIS: A REAL-WORLD STUDY
    Lucas, J.
    Wood, R.
    Piercy, J.
    Cappelleri, J. C.
    Kola, B.
    Chhabra, A.
    Vasilescu, R.
    Hsu, M. -A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1158 - 1158
  • [5] Changes in Patient-Reported Outcomes With Vedolizumab Therapy in Patients With Inflammatory Bowel Diseases (IBD): Results From the IBD Partners Patient Powered Research Network
    Long, Millie D.
    Martin, Christopher F.
    Chen, Wenli
    Luo, Michelle
    [J]. CROHNS & COLITIS 360, 2019, 1 (02)
  • [6] Changes in Patient-Reported Outcomes With Vedolizumab Therapy in Patients With Inflammatory Bowel Diseases (IBD)
    Long, Millie D.
    Martin, Christopher
    Chen, Wenli
    Jaeger, Elizabeth
    Barocas, Morris
    Luo, Michelle
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S342 - S342
  • [7] A real-world analysis of global patient-reported outcomes in patients with migraine
    Ford, Janet H.
    Cotton, Sarah
    Jackson, James
    Andrews, Jeffrey S.
    Foster, Shonda A.
    Ye, Wenyu
    Nichols, Russell M.
    Tockhorn-Heidenreich, Antje
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [8] Real-world biologic treatment and associated cost in patients with inflammatory bowel disease
    Brandes, Alina
    Groth, Antje
    Gottschalk, Fraence
    Wilke, Thomas
    Ratsch, Boris A.
    Orzechowski, Hans-Dieter
    Fuchs, Andreas
    Deiters, Barthold
    Bokemeyer, Bernd
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (07): : 843 - 851
  • [9] Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting
    Strober, Bruce
    Patil, Dhaval
    McLean, Robert R.
    Moore-Clingenpeel, Melissa
    Guo, Ning
    Levi, Eugenia
    Lebwohl, Mark
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (08) : 3178 - 3187
  • [10] The Real World Global Use of Patient-Reported Outcomes (PROs) for the Care of Patients With IBD
    Horrigan, Jamie
    Louis, Edouard
    Spinelli, Antonino
    Travis, Simon
    Moum, Bjorn
    Salwen-Deremer, Jessica
    Halfvarson, Jonas
    Panaccione, Remo
    Dubinsky, Marla C.
    Munkholm, Pia
    Siegel, Corey A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S704 - S705
12345